ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 112 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $6,681,000 | +138.9% | 2,257,167 | +28.4% | 0.01% | +100.0% |
Q4 2018 | $2,796,000 | -78.4% | 1,758,513 | -49.9% | 0.00% | -50.0% |
Q3 2018 | $12,928,000 | +163.5% | 3,512,886 | +102.6% | 0.01% | +33.3% |
Q2 2018 | $4,907,000 | -11.4% | 1,733,965 | +16.1% | 0.01% | -14.3% |
Q1 2018 | $5,540,000 | +23.9% | 1,493,266 | -3.8% | 0.01% | +16.7% |
Q4 2017 | $4,471,000 | -33.4% | 1,552,264 | +3.9% | 0.01% | -33.3% |
Q3 2017 | $6,710,000 | +2.6% | 1,494,482 | +4.8% | 0.01% | 0.0% |
Q2 2017 | $6,543,000 | +15.3% | 1,425,382 | +5.8% | 0.01% | +12.5% |
Q1 2017 | $5,674,000 | +45.6% | 1,347,858 | +42.9% | 0.01% | +33.3% |
Q4 2016 | $3,897,000 | -37.2% | 943,541 | +23.2% | 0.01% | -40.0% |
Q3 2016 | $6,205,000 | +323.8% | 766,004 | +308.1% | 0.01% | +233.3% |
Q2 2016 | $1,464,000 | +9.2% | 187,704 | +8.0% | 0.00% | +50.0% |
Q1 2016 | $1,341,000 | -28.5% | 173,752 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $1,875,000 | -44.9% | 173,752 | -64.7% | 0.00% | -42.9% |
Q3 2015 | $3,402,000 | -21.5% | 492,302 | +0.6% | 0.01% | -12.5% |
Q2 2015 | $4,336,000 | -9.1% | 489,421 | +1.2% | 0.01% | -11.1% |
Q1 2015 | $4,770,000 | -14.0% | 483,778 | +6.8% | 0.01% | -18.2% |
Q4 2014 | $5,547,000 | +6.9% | 452,819 | -12.9% | 0.01% | +10.0% |
Q3 2014 | $5,190,000 | +40.4% | 520,079 | +6.5% | 0.01% | +25.0% |
Q2 2014 | $3,696,000 | +649.7% | 488,279 | +225.9% | 0.01% | +700.0% |
Q1 2014 | $493,000 | -0.8% | 149,803 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $497,000 | +23.9% | 149,803 | +12.8% | 0.00% | 0.0% |
Q3 2013 | $401,000 | -62.0% | 132,823 | +2.9% | 0.00% | -66.7% |
Q2 2013 | $1,056,000 | – | 129,062 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|